Tenofovir renal safety in HIV-infected patients: Results from the SCOLTA ProjectGiordano Madeddu, for the CISAI Group, Giuseppe Vittorio De Socio et al.|Biomedicine & Pharmacotherapy|2007Cited by 74
QuantiFERON TB Gold: a new method for latent tuberculosis infection.Alessandra Bua, Stefania Zanetti, Paola Molicotti et al.|PubMed|2007Cited by 20
[Renal toxicity in HIV-infected patients receiving HAART including tenofovir].Giordano Madeddu, Paolo Bonfanti, Tiziana Quirino et al.|PubMed|2006Cited by 9
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcomeValeria Cento, Francesca Ceccherini‐Silberstein, Daniele Di Paolo et al.|Digestive and Liver Disease|2014Cited by 5
Tossicità renale in pazienti con infezione da HIV in trattamento con HAART contenente tenofovir Renal toxicity in HIV-infected patients receiving HAART includine tenofovirGiordano Madeddu, Paolo Bonfanti, Tiziana Quirino et al.|Unknown|2006Cited by 0